Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Large Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a significant decline in short interest in May. As of May 15th, there was short interest totaling 295 shares, a decline of 61.7% from the April 30th total of 770 shares. Based on an average daily volume of 64,427 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Institutional Trading of Fidelity Disruptive Medicine ETF

Hedge funds have recently bought and sold shares of the company. Glass Jacobson Investment Advisors llc lifted its position in Fidelity Disruptive Medicine ETF by 44.0% in the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after buying an additional 385 shares during the last quarter. Virtu Financial LLC bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth approximately $228,000. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth approximately $234,000. BXM Wealth LLC bought a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth approximately $243,000. Finally, Jane Street Group LLC lifted its position in Fidelity Disruptive Medicine ETF by 0.8% in the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock worth $1,567,000 after buying an additional 499 shares during the last quarter.

Fidelity Disruptive Medicine ETF Trading Down 1.0%

Shares of NASDAQ FMED traded down $0.26 during midday trading on Monday, hitting $24.91. 6,298 shares of the company’s stock were exchanged, compared to its average volume of 13,485. Fidelity Disruptive Medicine ETF has a 12-month low of $22.80 and a 12-month high of $29.07. The company has a market cap of $57.29 million, a price-to-earnings ratio of 41.33 and a beta of 0.84. The business’s fifty day moving average price is $24.84 and its two-hundred day moving average price is $26.17.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.